D’Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, et al.: Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991, 115: 343–349. 10.7326/0003-4819-115-5-343
Article
PubMed
Google Scholar
Sandoval J, Bauerle O, Palomar A, Gomez A, Martinez-Guerra ML, Beltran M, Guerrero ML: Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation 1994, 89: 1733–1744. 10.1161/01.CIR.89.4.1733
Article
CAS
PubMed
Google Scholar
van de Veerdonk T, Kind JT, Marcus GJ, Mauritz MW, Heymans HJ, Bogaard A, Boonstra KM, Marques NW, Vonk-Noordegraaf A: Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 2011, 58: 2511–2519. 10.1016/j.jacc.2011.06.068
Article
PubMed
Google Scholar
Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S: An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007, 30: 104–109. 10.1183/09031936.00092306
Article
CAS
PubMed
Google Scholar
Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, et al.: Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010, 122: 156–163. 10.1161/CIRCULATIONAHA.109.911818
Article
PubMed
Google Scholar
Nagendran J, Sutendra G, Paterson I, Champion HC, Webster L, Chiu B, Haromy A, Rebeyka IM, Ross DB, Michelakis ED: Endothelin axis is upregulated in human and rat right ventricular hypertrophy. Circ Res 2013, 112: 347–354. 10.1161/CIRCRESAHA.111.300448
Article
CAS
PubMed
Google Scholar
Nagendran J, Archer SL, Soliman D, Gurtu V, Moudgil R, Haromy A, Aubin C, Webster L, Rebeyka IM, Ross DB, et al.: Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 2007, 116: 238–248. 10.1161/CIRCULATIONAHA.106.655266
Article
CAS
PubMed
Google Scholar
Bogaard HJ, Natarajan R, Mizuno S, Abbate A, Chang P, Chau V, Hoke N, Kraskauskas D, Kasper M, Salloum F, et al.: Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. Am J Respir Crit Care Med 2010, 182: 652–660. 10.1164/rccm.201003-0335OC
Article
CAS
PubMed
Google Scholar
de Man FS, Handoko ML, Guignabert C, Bogaard HJ, Vonk-Noordegraaf A: Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe? Am J Respir Crit Care Med 2013, 187: 14–19. 10.1164/rccm.201209-1663PP
Article
CAS
PubMed
Google Scholar
Gomez-Arroyo J, Mizuno S, Szczepanek K, Van TB, Natarajan R, dos Remedios CG, Drake JI, Farkas L, Kraskauskas D, Wijesinghe DS, et al.: Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension. Circ Heart Fail 2013, 6: 136–144. 10.1161/CIRCHEARTFAILURE.111.966127
Article
CAS
PubMed Central
PubMed
Google Scholar
Gabler NB, French B, Strom BL, Palevsky HI, Taichman DB, Kawut SM, Halpern SD: Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials. Circulation 2012, 126: 349–356. 10.1161/CIRCULATIONAHA.112.105890
Article
CAS
PubMed Central
PubMed
Google Scholar
Voelkel NF, Gomez-Arroyo JG, Abbate A, Bogaard HJ, Nicolls MR: Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J 2012, 40: 1555–1565. 10.1183/09031936.00046612
Article
CAS
PubMed Central
PubMed
Google Scholar
Xu W, Koeck T, Lara AR, Neumann D, DiFilippo FP, Koo M, Janocha AJ, Masri FA, Arroliga AC, Jennings C, et al.: Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci USA 2007, 104: 1342–1347. 10.1073/pnas.0605080104
Article
CAS
PubMed Central
PubMed
Google Scholar
Zhao L, Ashek A, Wang L, Fang W, Dabral S, Dubois O, Cupitt J, Pullamsetti SS, Cotroneo E, Jones H, et al.: Heterogeneity in lung 18FDG uptake in PAH: potential of dynamic 18FDG-PET with kinetic analysis as a bridging biomarker for pulmonary remodeling targeted treatments. Circulation 2013, 128: 1214–1224.
Article
CAS
PubMed
Google Scholar
Hagan G, Southwood M, Treacy C, Ross RM, Soon E, Coulson J, Sheares K, Screaton N, Pepke-Zaba J, Morrell NW, et al.: (18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle study. Pulm. Circ. 2011, 1: 448–455. 10.4103/2045-8932.93543
Article
CAS
PubMed Central
PubMed
Google Scholar
Ruiter G, Wong YY, Raijmakers P, Huisman MC, Lammertsma AA, de Man FS, Westerhof N, van der Laarse WJ, Vonk-Noordegraaf A: Pulmonary 2-deoxy-2[18F]-fluoro-D-glucose uptake is low in treated patients with idiopathic pulmonary arterial hypertension. Pulm. Circ. 2013. Epub
Google Scholar
Brown M, Marshall DR, Sobel BE, Bergmann SR: Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation 1987, 76: 687–696. 10.1161/01.CIR.76.3.687
Article
CAS
PubMed
Google Scholar
Klein LJ, Visser FC, Knaapen P, Peters JH, Teule GJ, Visser CA, Lammertsma AA: Carbon-11 acetate as a tracer of myocardial oxygen consumption. Eur J Nucl Med 2001, 28: 651–668. 10.1007/s002590000472
Article
CAS
PubMed
Google Scholar
Timmer SA, Lubberink M, Van Rossum AC, Lammertsma AA, Knaapen P: Reappraisal of a single-tissue compartment model for estimation of myocardial oxygen consumption by [11C]acetate PET: an alternative to conventional monoexponential curve fitting. Nucl Med Commun 2011, 32: 59–62. 10.1097/MNM.0b013e32834113b0
Article
PubMed
Google Scholar
Direcks WG, Berndsen SC, Proost N, Peters GJ, Balzarini J, Spreeuwenberg MD, Lammertsma AA, Molthoff CF: [18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study. Br J Cancer 2008, 99: 481–487. 10.1038/sj.bjc.6604523
Article
CAS
PubMed Central
PubMed
Google Scholar
Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W, et al.: Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 2005, 115: 2811–2821. 10.1172/JCI24838
Article
CAS
PubMed Central
PubMed
Google Scholar
Al Husseini A, Bagnato G, Farkas L, Gomez-Arroyo J, Farkas D, Mizuno S, Kraskauskas D, Abbate A, Van Tassel Pharm DB, Voelkel NF, et al.: Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats. Eur Respir J 2013, 41: 104–114. 10.1183/09031936.00196511
Article
CAS
PubMed
Google Scholar
Overbeek MJ, Boonstra A, Voskuyl AE, Vonk MC, Vonk-Noordegraaf A, van Berkel MP, Mooi WJ, Dijkmans BA, Hondema LS, Smit EF, et al.: Platelet-derived growth factor receptor-beta and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case–control study. Arthritis Res Ther 2011, 13: R61. 10.1186/ar3315
Article
PubMed Central
PubMed
Google Scholar
Bahce I, Smit EF, Lubberink M, van der Veldt AA, Yaqub M, Windhorst AD, Schuit RC, Thunnissen E, Heideman DA, Postmus PE, et al.: Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status. Clin Cancer Res 2013, 19: 183–193. 10.1158/1078-0432.CCR-12-0289
Article
CAS
PubMed
Google Scholar
Bogaard HJ, Mizuno S, Guignabert C, Al Hussaini AA, Farkas D, Ruiter G, Kraskauskas D, Fadel E, Allegood JC, Humbert M, et al.: Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humans. Am J Respir Cell Mol Biol 2012, 46: 582–591. 10.1165/rcmb.2011-0296OC
Article
CAS
PubMed Central
PubMed
Google Scholar
Dijkgraaf I, Kruijtzer JA, Liu S, Soede AC, Oyen WJ, Corstens FH, Liskamp RM, Boerman OC: Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides. Eur J Nucl Med Mol Imaging 2007, 34: 267–273. 10.1007/s00259-006-0180-9
Article
CAS
PubMed
Google Scholar
Dijkgraaf I, Yim CB, Franssen GM, Schuit RC, Luurtsema G, Liu S, Oyen WJ, Boerman OC: PET imaging of alphavbeta integrin expression in tumours with Ga-labelled mono-, di- and tetrameric RGD peptides. Eur J Nucl Med Mol Imaging 2011, 38: 128–137. 10.1007/s00259-010-1615-x
Article
CAS
PubMed Central
PubMed
Google Scholar
Oude Munnink TH, Arjaans ME, Timmer-Bosscha H, Schroder CP, Hesselink JW, Vedelaar SR, Walenkamp AM, Reiss M, Gregory RC, Lub-de Hooge MN, et al.: PET with the 89Zr-labeled transforming growth factor-beta antibody fresolimumab in tumor models. J Nucl Med 2011, 52: 2001–2008. 10.2967/jnumed.111.092809
Article
CAS
PubMed
Google Scholar
Bogaard HJ, Abe K, Vonk-Noordegraaf A, Voelkel NF: The right ventricle under pressure; cellular and molecular mechanisms of right heart failure in pulmonary hypertension. Chest 2009, 135: 794–804. 10.1378/chest.08-0492
Article
CAS
PubMed
Google Scholar
Wong YY, Ruiter G, Lubberink M, Raijmakers PG, Knaapen P, Marcus JT, Boonstra A, Lammertsma AA, Westerhof N, van der Laarse WJ, et al.: Right ventricular failure in idiopathic pulmonary arterial hypertension is associated with inefficient myocardial oxygen utilization. Circ Heart Fail 2011, 4: 700–706. 10.1161/CIRCHEARTFAILURE.111.962381
Article
CAS
PubMed
Google Scholar
Wong YY, Westerhof N, Ruiter G, Lubberink M, Raijmakers P, Knaapen P, Marcus JT, Boonstra A, Lammertsma AA, van der Laarse WJ, et al.: Systolic pulmonary artery pressure and heart rate are main determinants of oxygen consumption in the right ventricular myocardium of patients with idiopathic pulmonary arterial hypertension. Eur J Heart Fail 2011, 13: 1290–1295. 10.1093/eurjhf/hfr140
Article
CAS
PubMed
Google Scholar
Kusachi S, Nishiyama O, Yasuhara K, Saito D, Haraoka S, Nagashima H: Right and left ventricular oxygen metabolism in open-chest dogs. Am J Physiol 1982, 243: H761-H766.
CAS
PubMed
Google Scholar
van Wolferen SA, Marcus JT, Westerhof N, Spreeuwenberg MD, Marques KM, Bronzwaer JG, Henkens IR, Gan CT, Boonstra A, Postmus PE, et al.: Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J 2008, 29: 120–127.
Article
PubMed
Google Scholar
Wong YY, Raijmakers PG, Knaapen P, Lubberink M, Ruiter G, Marcus JT, Boonstra A, Lammertsma AA, Westerhof N, van der Laarse WJ, et al.: Supine-exercise-induced oxygen supply to the right myocardium is attenuated in patients with severe idiopathic pulmonary arterial hypertension. Br Heart J 2011, 97: 2069–2074. 10.1136/heartjnl-2011-300237
Article
CAS
Google Scholar
Vogel-Claussen J, Skrok J, Shehata ML, Singh S, Sibley CT, Boyce DM, Lechtzin N, Girgis RE, Mathai SC, Goldstein TA, et al.: Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension. Radiology 2011, 258: 119–127. 10.1148/radiol.10100725
Article
PubMed Central
PubMed
Google Scholar
Gomez A, Bialostozky D, Zajarias A, Santos E, Palomar A, Martinez ML, Sandoval J: Right ventricular ischemia in patients with primary pulmonary hypertension. J Am Coll Cardiol 2001, 38: 1137–1142. 10.1016/S0735-1097(01)01496-6
Article
CAS
PubMed
Google Scholar
Neubauer S: The failing heart--an engine out of fuel. N. Engl. J. Med. 2007, 356: 1140–1151. 10.1056/NEJMra063052
Article
PubMed
Google Scholar
Piao L, Fang YH, Cadete VJ, Wietholt C, Urboniene D, Toth PT, Marsboom G, Zhang HJ, Haber I, Rehman J, et al.: The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol. Med (Berl). 2010, 88: 47–60. 10.1007/s00109-009-0524-6
Article
CAS
Google Scholar
Nagaya N, Goto Y, Satoh T, Uematsu M, Hamada S, Kuribayashi S, Okano Y, Kyotani S, Shimotsu Y, Fukuchi K, et al.: Impaired regional fatty acid uptake and systolic dysfunction in hypertrophied right ventricle. J Nucl Med 1998, 39: 1676–1680.
CAS
PubMed
Google Scholar
Oikawa M, Kagaya Y, Otani H, Sakuma M, Demachi J, Suzuki J, Takahashi T, Nawata J, Ido T, Watanabe J, et al.: Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol 2005, 45: 1849–1855. 10.1016/j.jacc.2005.02.065
Article
CAS
PubMed
Google Scholar
Fang W, Zhao L, Xiong CM, Ni XH, He ZX, He JG, Wilkins MR: Comparison of 18F-FDG uptake by right ventricular myocardium in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease. Pulm. Circ. 2012, 2: 365–372. 10.4103/2045-8932.101651
Article
PubMed Central
PubMed
Google Scholar
Bokhari S, Raina A, Rosenweig EB, Schulze PC, Bokhari J, Einstein AJ, Barst RJ, Johnson LL: PET imaging may provide a novel biomarker and understanding of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension. Circ Cardiovasc Imaging 2011, 4: 641–647. 10.1161/CIRCIMAGING.110.963207
Article
PubMed
Google Scholar
Can MM, Kaymaz C, Tanboga IH, Tokgoz HC, Canpolat N, Turkyilmaz E, Sonmez K, Ozdemir N: Increased right ventricular glucose metabolism in patients with pulmonary arterial hypertension. Clin Nucl Med 2011, 36: 743–748. 10.1097/RLU.0b013e3182177389
Article
PubMed
Google Scholar
Kluge R, Barthel H, Pankau H, Seese A, Schauer J, Wirtz H, Seyfarth HJ, Steinbach J, Sabri O, Winkler J: Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension. J Nucl Med 2005, 46: 25–31.
CAS
PubMed
Google Scholar
Sutendra G, Dromparis P, Paulin R, Zervopoulos S, Haromy A, Nagendran J, Michelakis ED: A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension. J Mol Med (Berl) 2013, 91: 1315–1327. 10.1007/s00109-013-1059-4
Article
CAS
Google Scholar
Bogaard HJ, Natarajan R, Henderson SC, Long CS, Kraskauskas D, Smithson L, Ockaili R, McCord JM, Voelkel NF: Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 2009, 120: 1951–1960. 10.1161/CIRCULATIONAHA.109.883843
Article
PubMed
Google Scholar
Rodriguez-Porcel M, Cai W, Gheysens O, Willmann JK, Chen K, Wang H, Chen IY, He L, Wu JC, Li ZB, et al.: Imaging of VEGF receptor in a rat myocardial infarction model using PET. J Nucl Med 2008, 49: 667–673. 10.2967/jnumed.107.040576
Article
PubMed Central
PubMed
Google Scholar
Higuchi T, Bengel FM, Seidl S, Watzlowik P, Kessler H, Hegenloh R, Reder S, Nekolla SG, Wester HJ, Schwaiger M: Assessment of alphavbeta3 integrin expression after myocardial infarction by positron emission tomography. Cardiovasc Res 2008, 78: 395–403. 10.1093/cvr/cvn033
Article
CAS
PubMed
Google Scholar
Meoli DF, Sadeghi MM, Krassilnikova S, Bourke BN, Giordano FJ, Dione DP, Su H, Edwards DS, Liu S, Harris TD, et al.: Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest 2004, 113: 1684–1691.
Article
CAS
PubMed Central
PubMed
Google Scholar
Pietila M, Malminiemi K, Ukkonen H, Saraste M, Nagren K, Lehikoinen P, Voipio-Pulkki LM: Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure. Eur J Nucl Med 2001, 28: 373–376. 10.1007/s002590000449
Article
CAS
PubMed
Google Scholar
Wichter T, Schafers M, Rhodes CG, Borggrefe M, Lerch H, Lammertsma AA, Hermansen F, Schober O, Breithardt G, Camici PG: Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy : quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. Circulation 2000, 101: 1552–1558. 10.1161/01.CIR.101.13.1552
Article
CAS
PubMed
Google Scholar
Fukushima K, Bravo PE, Higuchi T, Schuleri KH, Lin X, Abraham MR, Xia J, Mathews WB, Dannals RF, Lardo AC, et al.: Molecular hybrid positron emission tomography/computed tomography imaging of cardiac angiotensin II type 1 receptors. J Am Coll Cardiol 2012, 60: 2527–2534. 10.1016/j.jacc.2012.09.023
Article
CAS
PubMed Central
PubMed
Google Scholar
Nensa F, Poeppel TD, Beiderwellen K, Schelhorn J, Mahabadi AA, Erbel R, Heusch P, Nassenstein K, Bockisch A, Forsting M, et al.: Hybrid PET/MR imaging of the heart: feasibility and initial results. Radiology 2013, 268: 366–373. 10.1148/radiol.13130231
Article
PubMed
Google Scholar
Schlosser T, Nensa F, Mahabadi AA, Poeppel TD: Hybrid MRI/PET of the heart: a new complementary imaging technique for simultaneous acquisition of MRI and PET data. Br Heart J 2013, 99: 351–352. 10.1136/heartjnl-2012-302740
Article
Google Scholar
Ibrahim T, Nekolla SG, Langwieser N, Rischpler C, Groha P, Laugwitz KL, Schwaiger M: Simultaneous positron emission tomography/magnetic resonance imaging identifies sustained regional abnormalities in cardiac metabolism and function in stress-induced transient midventricular ballooning syndrome: a variant of Takotsubo cardiomyopathy. Circulation 2012, 126: e324-e326. 10.1161/CIRCULATIONAHA.112.134346
Article
PubMed
Google Scholar
Hofmann M, Steinke F, Scheel V, Charpiat G, Farquhar J, Aschoff P, Brady M, Scholkopf B, Pichler BJ: MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration. J Nucl Med 2008, 49: 1875–1883. 10.2967/jnumed.107.049353
Article
PubMed
Google Scholar
Zaidi H: Is MR-guided attenuation correction a viable option for dual-modality PET/MR imaging? Radiology 2007, 244: 639–642. 10.1148/radiol.2443070092
Article
PubMed
Google Scholar